Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
140.12
+3.55 (2.60%)
At close: Aug 5, 2025, 4:00 PM
139.90
-0.22 (-0.16%)
After-hours: Aug 5, 2025, 7:59 PM EDT
Ligand Pharmaceuticals Market Cap
Natera has a market cap or net worth of $19.13 billion as of August 5, 2025. Its market cap has increased by 54.03% in one year.
Market Cap
19.13B
Enterprise Value
18.34B
1-Year Change
54.03%
Ranking
Category
Stock Price
$140.12
Market Cap Chart
Since July 2, 2015, Natera's market cap has increased from $1.10B to $19.13B, an increase of 1,637.46%. That is a compound annual growth rate of 32.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 18.65B | -10.77% |
| Dec 31, 2024 | 20.90B | 177.68% |
| Dec 29, 2023 | 7.53B | 91.96% |
| Dec 30, 2022 | 3.92B | -55.62% |
| Dec 31, 2021 | 8.83B | 3.98% |
| Dec 31, 2020 | 8.50B | 225.28% |
| Dec 31, 2019 | 2.61B | 202.62% |
| Dec 31, 2018 | 863.10M | 78.55% |
| Dec 29, 2017 | 483.40M | -21.19% |
| Dec 30, 2016 | 613.40M | 13.59% |
| Dec 31, 2015 | 540.00M | -50.96% |
| Jul 2, 2015 | 1.10B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |